🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Gallbladder Cancer

Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma NCT07780838Phase 21 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Cisplatin, Computed Tomography, Durvalumab, Gemcitabine Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer NCT07614061Phase 11 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: BTC-Ag-T (ACH-AgT001), Cyclophosphamide and Fludarabine Robotic-assisted Contra Open Resection for Suspected or Confirmed Gallbladder Cancer (ROBOCOP) NCT06246448NA1 site📍 Stockholm Karolinska University Hospital · Tests: Robotic-assisted radical cholecystectomy, Open radical cholecystectomy TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients NCT07480785NA1 site📍 Hangzhou Zhejiang University · Tests: transcutaneous electrical acupoint stimulation, Sham transcutaneous electrical acupoint stimulation, triple antiemetic … Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer NCT05184400n/a1 site📍 Herlev Herlev and Gentofte Hospital Incidental Gallbladder Carcinoma :Incidence and Clinical Significance in Specimens From Routine Cholecystectomies in Sohag Locality NCT07885800n/a1 site📍 Sohag Sohag University · Tests: histopathology of gall bladder Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors NCT07334119Phase 17 sites📍 Darlinghurst📍 Randwick📍 Waratah Myeloid Therapeutics · Tests: MT-304, MT-304 + Nivolumab Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) NCT06101277NA1 site📍 Sacramento University of California, Davis · Tests: Ablative local therapy Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors NCT06239194Phase 1, Phase 26 sites📍 Denver📍 Miami📍 Boston ModeX Therapeutics, An OPKO Health Company · Tests: MDX2001 Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB) NCT06712420Phase 33 sites📍 Delhi📍 Delhi📍 Delhi Rajiv Gandhi Cancer Institute & Research Center, India · Tests: neoadjuvant chemotherapy, curative surgery Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers NCT07337850n/a1 site📍 Mumbai Tata Memorial Centre · Tests: gallium-68-Fibroblast Activation Protein Inhibitor Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery. NCT04735198NA6 sites📍 Badalona📍 Barcelona📍 Barcelona Hospital Universitari de Bellvitge · Tests: Primary tumor surgery, Primary tumor surgery (bowel resection) combined with prophylactic cholecystectomy STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy NCT06123117NA1 site📍 Espoo Helsinki University Central Hospital · Tests: single transversus abdominis laparoscopy-guided plane block, local trocar site ropivacaine infiltration Radiation Therapy in Unresectable Gall Bladder Cancer NCT06214572Phase 2, Phase 31 site📍 Mumbai Tata Memorial Centre · Tests: Systemic therapy (Gemcitabine plus Cisplatin), RT, Systemic therapy (Gemcitabine plus oxaliplatin), Systemic therapy (G… A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer NCT07265674Phase 318 sites📍 Duarte📍 Orange📍 Santa Monica J-Pharma Co., Ltd. · Tests: Nanvuranlat, Physician's Best Choice Efficacy and Safety of Postoperative Concurrent Chemoradiotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma: A Multicenter Prospective Phase II Study NCT07636824Phase 21 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Postoperative radiotherapy, Capecitabine or S-1 EULAT Eradicate GBC NCT06192719n/a36 sites📍 Salta📍 Salta📍 San Salvador de Jujuy Centre Paul Strauss · Tests: None, observational study. A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs NCT06423170Phase 21 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: Camrelizumab plus GEMOX Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors NCT07726446Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: PD-1 and chemotherapy, cryoablation Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery NCT06926374NA1 site📍 Hong Kong Chinese University of Hong Kong · Tests: Robotic surgery using the Sentire Surgical System NGS in Gallbladder Cancer and Response to Treatment NCT05404347n/a1 site📍 Varanasi Banaras Hindu University · Tests: Next generation sequencing The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) NCT04585750Phase 1, Phase 276 sites📍 Irvine📍 La Jolla📍 Los Angeles PMV Pharmaceuticals, Inc · Tests: rezatapopt, pembrolizumab A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) NCT06760819Phase 254 sites📍 Birmingham📍 Duarte📍 Fort Myers Bayer · Tests: BAY2927088 A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02) NCT07221253Phase 3183 sites📍 Birmingham📍 Phoenix📍 Tucson AstraZeneca · Tests: Rilvegostomig, Durvalumab, Gemcitabine/Cisplatin Target-specific immunoPET Imaging of Digestive System Carcinoma NCT06715839NA1 site📍 Shanghai RenJi Hospital · Tests: [68Ga]Ga-DOTA-H2D3, [18F]F-RESCA-RB14, [68Ga]Ga-NOTA-T4, [18F]F-RESCA-T4, [68Ga]Ga-NOTA-G5 Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors NCT05732831Phase 1, Phase 226 sites📍 Palo Alto📍 Grand Junction📍 Lake Mary Tango Therapeutics, Inc. · Tests: TNG462, Pembrolizumab A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening NCT07176962n/a1 site📍 Shanghai Yingbin Liu, MD, PhD, FACS The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer NCT03637569n/a1 site📍 Seoul Samsung Medical Center · Tests: Measurement of triceps skinfold thickness Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer NCT07025174Phase 21 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: PD-1/CTLA-4 Dual Functional Antibody, Gemcitabine, Cisplatin, Anlotinib, Oxaliplatin + 5-Fluorouracil/Leucovorin
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy